HbE is a common hemoglobin variant causing only minimal red cell abnormalities in carriers. Alpha-globin gene defects may cause decreased MCV and reduction of the percentage of HbE. 1 Molecular analysis involves gap-PCR for the most common alpha-thalassemia rearrangements and covers over 80% of all alpha-thalassemia defects. Less frequently point mutations or unknown deletions are involved, which can be detected by Sanger sequencing and MLPA. Sometimes, the combination of HbE and alpha-thalassemia may go undetected if molecular analysis is not standardly performed, especially if the HPLC does not show a reduced percentage of HbE. Depending on the type of Hb variant or alpha-thalassemia defect, this could have serious consequences for counseling. Hb Adana F I G U R E 1 A, Capillary electrophoresis results showed 76% HbA, 3% HbA2, 0 and 20.2% HbE. B, High-performance liquid chromatography results showed 59.1% HbA, 3.7% HbA2, 0.2% HbF, and 25.8% HbE. The HbE and HbA2 peaks were not completely separated in HPLC which could explain the slight overestimation of the HbE level in our patient. With CE, the HbE level was slightly decreased compared to HPLC and to the literature for a plain HbE carrier. No HbH or Hb Bart's have been shown in the two graphs [Colour figure can be viewed at wileyonlinelibrary.com] (A) (B)
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LETTER TO THE EDITOR (c.179G>A), a highly unstable alpha-globin gene variant, interacts with deletional and nondeletional mutations to produce HbH disorders with varying clinical manifestations from asymptomatic to severe anemia with significant hepatosplenomegaly. The most severe form of HbH disorders is the HbH hydrops fetalis, where the fetus usually dies in utero or shortly after birth due to a severe intrauterine hemolytic anemia. 2 Here, we report, to our knowledge, the first case of a carrier of HbE (c.79G>A p.Glu27Lys) and the highly unstable Hb Adana variant (HbA2: c.179G>A p.Gly60Asp). We present a case of a 53-year-old man with normal MCV, a slightly decreased MCH without anemia. Biochemical assays showed a borderline decreased percentage of HbE in capillary electrophoresis (CE) but normal HbE levels in high-performance liquid chromatography (HPLC) which could easily have been mistaken for a regular HbE carrier. Hb Adana was detected by alpha-globin gene sequencing following a negative gap-PCR result for the seven most common alpha-thalassemia deletions.
The complete blood count (CBC) (Horiba medical, ABX Micros 4 Especially when on the dominantly expressed alpha 2-globin gene, this mutation may even cause HbH hydrops fetalis in homozygosity or in combination with alpha 0-thalassemia. 2, 5 Due to its unstable nature, heterozygosity for Hb Adana is not visible by routine biochemical assay such as HPLC and CE, 6 but the carrier does present with microcytic hypochromic parameters. As carriers of HbE may also present with mild microcytic hypochromic parameters, the co-inheritance of alpha-thalassemia defects could be easily overlooked unless the HbE percentage is taken into account, which is usually slightly decreased in those cases. In our case, the decrease in percentage of HbE was only visible on CE, while the hematology (normal MCV) and the percentage of HbE on HPLC
Parameters
Patient results A complicating feature in the quantification of the HbE fraction may be the overestimation of HbE due to the inability to separate it from HbA 2 by many HPLC systems presently used for hemoglobinopathy diagnostics. 7 The Premier High Resolution (Trinity Biotech) HPLC system used is capable of separating HbE from HbA 2 ; however, as shown in Figure 1 In conclusion, our case confirms that hematologists evaluating patients with anemia should perform a thorough evaluation for alphathalassemia, which, besides the commonly used gap-PCR for the seven most common deletions, should also include alpha-globin gene sequencing. Careful evaluation of both hematological, biochemical separation, and DNA analysis is essential to diagnosis all combinations of beta and alpha-globin gene defects in order to determine precise genetic risk in the carriers to provide adequate genetic counseling. 12
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